Fatal cardiac arrhythmia after oral sumatriptan

Headache

Volumn 39, Issue 7, 1999, Pages 511-512

  Raasakka, T ^b   Mantynen J ^b   Saukko, P ^b   Laine, Kari ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b NONE

Author keywords

Cardiac arrhythmia; Death; Sumatriptan; Vasospasm

Indexed keywords

SUMATRIPTAN;

ADULT; ARTICLE; CASE REPORT; DEFIBRILLATION; FATALITY; FEMALE; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; MIGRAINE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0345425095     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1999.3907511.x     Document Type: Article

References (7)

1. Brown EG, Endersby CA, Smith RN, Talbot JC. The safety and tolerability of sumatriptan: an overview. Eur Neurol. 1991;31:339-344.
2. Willett F, Curzen N, Adams J, Armitage M. Coronary vasospasm induced by subcutaneous sumatriptan. BMJ. 1992;304:1415.
3. Mueller L, Gallagher RM, Ciervo CA. Vasospasm-induced myocardial infarction with sumatriptan. Headache. 1996;36:329-331.
4. O'Connor P, Gladstone P. Oral sumatriptan-associated transmural myocardial infarction. Neurology. 1995;45:2274-2276.
5. Jayamaha JE, Street MK. Fatal cerebellar infarction in a migraine sufferer whilst receiving sumatriptan. Intensive Care Med. 1995;21:82-83.
6. Dechant KL, Clissold SP. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs. 1992:43: 776-798.
7. Dixon CM, Park GR, Tarbit MH. Characterization of the enzyme responsible for the metabolism of sumatriptan in human liver. Biochem Pharmacol. 1994; 47:1253-1257.